Benitec Biopharma enters registration rights agreement with Averill funds related to direct offering

Benitec Biopharma Inc.

Registration Rights Agreement with Averill Master Fund and Averill Madison Master Fund dated March 26, 2025.
Company must file resale registration statement for shares sold in direct offering within 60 days of closing.
Company must use best efforts to have registration declared effective by 90th day (120th if full SEC review).
Agreement provides customary indemnification obligations between company and purchasers.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.